Functional heterogeneity of CD4+ T cells in liver inflammation
Open accessThe DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
CD4+ T cells play an essential role in orchestrating adequate immunity, but their overactivity has been associated with the development of immune-mediated inflammatory diseases, including liver inflammatory diseases. These cells can be subclassified according to their maturation stage, cytokine profile, and pro or anti-inflammatory functions, i.e., functional heterogeneity. In this review, we summarize what has been discovered so far regarding the role of the different CD4+ T cell polarization states in the progression of two prominent and still different liver inflammatory diseases: non-alcoholic steatohepatitis (NASH) and autoimmune hepatitis (AIH). Finally, the potential of CD4+ T cells as a therapeutic target in both NASH and AIH is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies in AIDs, including NMOSD, mainly identify T cells with pro-inflammatory or B cell helper function. 16,24-31”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Auto-Th cells with a pro-inflammatory or B cell helper profile are seen in AID patients, 16,24-31 but comprehensive ex vivo analyses are missing.”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Fate mapping of IL-17-producing T cells in inflammatory responses
Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. (2011) · Nature Immunology · doi:10.1038/ni.1993 · Cited by 1,176
Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., DeFor, T., Levine, B. L., June, C. H., Rubinstein, P., et al. (2011) · Blood · doi:10.1182/blood-2010-07-293795 · Cited by 1,045
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
Visualizing the generation of memory CD4 T cells in the whole body
Reinhardt, R. L., Khoruts, A., Merica, R., Zell, T., & Jenkins, M. K. (2001) · Nature · doi:10.1038/35065111 · Cited by 1,026
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs
Cyster, J. G. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115628 · Cited by 856
Memory T Cell Subsets, Migration Patterns, and Tissue Residence
Mueller, S. N., Gebhardt, T., Carbone, F. R., & Heath, W. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095954 · Cited by 839
Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation
Gagliani, N., Vesely, M. C. A., Iseppon, A., Brockmann, L., Xu, H., Palm, N. W., de Zoete, M. R., Licona-Limón, P., Paiva, R. S., Ching, T., et al. (2015) · Nature · doi:10.1038/nature14452 · Cited by 802
Self-citationNAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766
Chemokines as regulators of T cell differentiation
Luther, S. A., & Cyster, J. G. (2001) · Nature Immunology · doi:10.1038/84205 · Cited by 736
Trzonkowski, P., Bieniaszewska, M., Juścińska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Myśliwska, J., & Hellmann, A. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.06.001 · Cited by 683
Lymphocyte Trafficking and Regional Immunity
(1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60022-x · Cited by 674
TH2 cell development and function
Walker, J. A., & McKenzie, A. N. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.118 · Cited by 632
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.023 · Cited by 628
Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Mitra, S., De, A., & Chowdhury, A. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.09.08 · Cited by 513
Todo, S., Yamashita, K., Goto, R., Zaitsu, M., Nagatsu, A., Oura, T., Watanabe, M., Aoyagi, T., Suzuki, T., Shimamura, T., et al. (2016) · Hepatology · doi:10.1002/hep.28459 · Cited by 441
Marek-Trzonkowska, N., Myśliwiec, M., Dobyszuk, A., Grabowska, M., Techmańska, I., Juścińska, J., Wujtewicz, M. A., Witkowski, P., Młynarski, W., Balcerska, A., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0038 · Cited by 431
Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis
Harbour, S. N., Maynard, C. L., Zindl, C. L., Schoeb, T. R., & Weaver, C. T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415675112 · Cited by 427
Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., & Kaufmann, S. H. E. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.011 · Cited by 410
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
Longhi, M. S., Ma, Y., Bogdanos, D. P., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.008 · Cited by 405
Gomes, A. L., Teijeiro, A., Burén, S., Tummala, K. S., Yilmaz, M., Waisman, A., Theurillat, J.-P., Perna, C., & Djouder, N. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.020 · Cited by 401
Wong, J., Johnston, B., Lee, S. S., Bullard, D. C., Smith, C. W., Beaudet, A. L., & Kubes, P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119468 · Cited by 392
Autoimmune hepatitis – Update 2015
Manns, M. P., Lohse, A. W., & Vergani, D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.005 · Cited by 371
Grønbæk, L., Vilstrup, H., & Jepsen, P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.020 · Cited by 355
Rahman, K., Desai, C., Iyer, S. S., Thorn, N. E., Kumar, P., Liu, Y., Smith, T., Neish, A. S., Li, H., Tan, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.022 · Cited by 334
Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
You, Q., Cheng, L., Kedl, R. M., & Ju, C. (2008) · Hepatology · doi:10.1002/hep.22395 · Cited by 331
Tan, Z., Qian, X., Jiang, R., Liu, Q., Wang, Y., Chen, C., Wang, X., Ryffel, B., & Sun, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203013 · Cited by 330
Rau, M., Schilling, A.-K., Meertens, J., Hering, I., Weiss, J., Jurowich, C., Kudlich, T., Hermanns, H. M., Bantel, H., Beyersdorf, N., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501175 · Cited by 302
KNOLLE, P., SCHMITT, E., JIN, S., GERMANN, T., DUCHMANN, R., HEGENBARTH, S., GERKEN, G., & LOHSE, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70508-1 · Cited by 298
Horst, A. K., Neumann, K., Diehl, L., & Tiegs, G. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.112 · Cited by 295
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Tang, Y., Bian, Z., Zhao, L., Liu, Y., Liang, S., Wang, Q., Han, X., Peng, Y., Chen, X., Shen, L., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04471.x · Cited by 294
Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278
Heneghan, M. A., Yeoman, A. D., Verma, S., Smith, A. D., & Longhi, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62163-1 · Cited by 277
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH
Sutti, S., Jindal, A., Locatelli, I., Vacchiano, M., Gigliotti, L., Bozzola, C., & Albano, E. (2014) · Hepatology · doi:10.1002/hep.26749 · Cited by 270
Liver antigen-presenting cells
Crispe, I. N. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.005 · Cited by 262
IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
Harley, I. T. W., Stankiewicz, T. E., Giles, D. A., Softic, S., Flick, L. M., Cappelletti, M., Sheridan, R., Xanthakos, S. A., Steinbrecher, K. A., Sartor, B. R., et al. (2014) · Hepatology · doi:10.1002/hep.26746 · Cited by 250
TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells
Carambia, A., Freund, B., Schwinge, D., Heine, M., Laschtowitz, A., Huber, S., Wraith, D. C., Korn, T., Schramm, C., Lohse, A. W., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.027 · Cited by 241
Bertola, A., Bonnafous, S., Anty, R., Patouraux, S., Saint-Paul, M.-C., Iannelli, A., Gugenheim, J., Barr, J., Mato, J. M., Le Marchand-Brustel, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013577 · Cited by 240
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
Van Herck, M. A., Weyler, J., Kwanten, W. J., Dirinck, E. L., De Winter, B. Y., Francque, S. M., & Vonghia, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00082 · Cited by 238
Breous, E., Somanathan, S., Vandenberghe, L. H., & Wilson, J. M. (2009) · Hepatology · doi:10.1002/hep.23043 · Cited by 237
Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis
Weiler-Normann, C., Schramm, C., Quaas, A., Wiegard, C., Glaubke, C., Pannicke, N., Möller, S., & Lohse, A. W. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.010 · Cited by 236
Oo, Y. H., Weston, C. J., Lalor, P. F., Curbishley, S. M., Withers, D. R., Reynolds, G. M., Shetty, S., Harki, J., Shaw, J. C., Eksteen, B., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901216 · Cited by 232
Zhao, L., Tang, Y., You, Z., Wang, Q., Liang, S., Han, X., Qiu, D., Wei, J., Liu, Y., Shen, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018909 · Cited by 227
Lohse, A., Knolle, P., Bilo, K., Uhrig, A., Waldmann, C., Ibe, M., Schmitt, E., Gerken, G., & Meyer Zum Buschenfelde, K. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613007 · Cited by 226
Farhadi, A., Gundlapalli, S., Shaikh, M., Frantzides, C., Harrell, L., Kwasny, M. M., & Keshavarzian, A. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01723.x · Cited by 224
Doherty, D. G., Donaldson, P. T., Underhill, J. A., Farrant, M. J., Duthie, A., Mieli-Vergani, G., McFarlane, I. G., Johnson, P. J., Eddleston, A. L. W. F., Mowat, A. P., et al. (1994) · Hepatology · doi:10.1002/hep.1840190311 · Cited by 219
Distinctly altered gut microbiota in the progression of liver disease
Xie, G., Wang, X., Liu, P., Wei, R., Chen, W., Rajani, C., Hernandez, B. Y., Alegado, R., Dong, B., Li, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8466 · Cited by 219
Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity
Karmaus, P. W. F., Chen, X., Lim, S. A., Herrada, A. A., Nguyen, T.-L. M., Xu, B., Dhungana, Y., Rankin, S., Chen, W., Rosencrance, C., et al. (2019) · Nature · doi:10.1038/s41586-018-0806-7 · Cited by 215
Significance of HLA DR4 in type 1 autoimmune hepatitis
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Moore, S. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90157-8 · Cited by 206
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation
Sánchez-Fueyo, A., Whitehouse, G., Grageda, N., Cramp, M. E., Lim, T. Y., Romano, M., Thirkell, S., Lowe, K., Fry, L., Heward, J., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15700 · Cited by 206
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
Fragoulis, G. E., Siebert, S., & McInnes, I. B. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051914-021944 · Cited by 201
A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury
Ma, X., Hua, J., Mohamood, A. R., Hamad, A. R. A., Ravi, R., & Li, Z. (2007) · Hepatology · doi:10.1002/hep.21823 · Cited by 198
FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
Peiseler, M., Sebode, M., Franke, B., Wortmann, F., Schwinge, D., Quaas, A., Baron, U., Olek, S., Wiegard, C., Lohse, A. W., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.029 · Cited by 190
Grant, C. R., Liberal, R., Holder, B. S., Cardone, J., Ma, Y., Robson, S. C., Mieli-Vergani, G., Vergani, D., & Longhi, M. S. (2014) · Hepatology · doi:10.1002/hep.26583 · Cited by 188
Jaruga, B., Hong, F., Kim, W.-H., & Gao, B. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00184.2004 · Cited by 168
Herkel, J., Jagemann, B., Wiegard, C., Lazaro, J. F. G., Lueth, S., Kanzler, S., Blessing, M., Schmitt, E., & Lohse, A. W. (2003) · Hepatology · doi:10.1053/jhep.2003.50191 · Cited by 164
Lüth, S., Huber, S., Schramm, C., Buch, T., Zander, S., Stadelmann, C., Brück, W., Wraith, D. C., Herkel, J., & Lohse, A. W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32132 · Cited by 161
Th17 cells and their associated cytokines in liver diseases
Lafdil, F., Miller, A. M., Ki, S. H., & Gao, B. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.5 · Cited by 159
Rolla, S., Alchera, E., Imarisio, C., Bardina, V., Valente, G., Cappello, P., Mombello, C., Follenzi, A., Novelli, F., & Carini, R. (2016) · Clinical Science · doi:10.1042/cs20150405 · Cited by 158
Taubert, R., Hardtke‐Wolenski, M., Noyan, F., Wilms, A., Baumann, A. K., Schlué, J., Olek, S., Falk, C. S., Manns, M. P., & Jaeckel, E. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.034 · Cited by 155
Haas, J. T., Vonghia, L., Mogilenko, D. A., Verrijken, A., Molendi-Coste, O., Fleury, S., Deprince, A., Nikitin, A., Woitrain, E., Ducrocq-Geoffroy, L., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0076-1 · Cited by 155
Fabre, T., Kared, H., Friedman, S. L., & Shoukry, N. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400861 · Cited by 150
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
Fantuzzi, L., Tagliamonte, M., Gauzzi, M. C., & Lopalco, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03255-6 · Cited by 150
Jaruga, B., Hong, F., Sun, R., Radaeva, S., & Gao, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3233 · Cited by 149
Role of primary intrahepatic T‐cell activation in the ‘liver tolerance effect’
Bertolino, P., McCaughan, G. W., & Bowen, D. G. (2002) · Immunology & Cell Biology · doi:10.1046/j.0818-9641.2001.01048.x · Cited by 147
Li, W., Kuhr, C. S., Zheng, X. X., Carper, K., Thomson, A. W., Reyes, J. D., & Perkins, J. D. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02300.x · Cited by 147
Dunham, R. M., Thapa, M., Velazquez, V. M., Elrod, E. J., Denning, T. L., Pulendran, B., & Grakoui, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201937 · Cited by 144
Cellular and Molecular Mechanisms of Autoimmune Hepatitis
Webb, G. J., Hirschfield, G. M., Krawitt, E. L., & Gershwin, M. E. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043534 · Cited by 142
Nishioji, K., Okanoue, T., Itoh, Y., Narumi, S., Sakamoto, M., Nakamura, H., Morita, A., & Kashima, K. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2001.01391.x · Cited by 139
Balitzer, D. J., Shafizadeh, N., Peters, M. G., Ferrell, L. D., Alshak, N. S., & Kakar, S. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.267 · Cited by 138
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
Oo, Y. H., Hübscher, S. G., & Adams, D. (2010) · Hepatology International · doi:10.1007/s12072-010-9183-5 · Cited by 130
Cutting edge issues in autoimmune hepatitis
Liberal, R., Krawitt, E. L., Vierling, J. M., Manns, M. P., Mieli‐Vergani, G., & Vergani, D. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.07.005 · Cited by 129
Giles, D. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Huppert, S. S., Iwakura, Y., Dong, C., Shanmukhappa, S. K., & Divanovic, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149783 · Cited by 116
Liver Sinusoidal Endothelial Cells Are Insufficient to Activate T Cells
Katz, S. C., Pillarisetty, V. G., Bleier, J. I., Shah, A. B., & DeMatteo, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.230 · Cited by 115
Inzaugarat, M. E., Ferreyra Solari, N. E., Billordo, L. A., Abecasis, R., Gadano, A. C., & Cherñavsky, A. C. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9571-1 · Cited by 115
Lafdil, F., Wang, H., Park, O., Zhang, W., Moritoki, Y., Yin, S., Fu, X. Y., Gershwin, M. E., Lian, Z., & Gao, B. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.004 · Cited by 112
Pathogen-induced tissue-resident memory T H 17 (T RM 17) cells amplify autoimmune kidney disease
Krebs, C. F., Reimers, D., Zhao, Y., Paust, H.-J., Bartsch, P., Nuñez, S., Rosemblatt, M. V., Hellmig, M., Kilian, C., Borchers, A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba4163 · Cited by 109
Self-citationLapierre, P., Béland, K., Yang, R., & Alvarez, F. (2013) · Hepatology · doi:10.1002/hep.26023 · Cited by 108
Nagata, T., Mckinley, L., Peschon, J. J., Alcorn, J. F., Aujla, S. J., & Kolls, J. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7473 · Cited by 99
Lohr, H. F., Schlaak, J. F., Lohse, A. W., Bocher, W. O., Arenz, M., Gerken, G., & Buschenfelde, K. M. (1996) · Hepatology · doi:10.1002/hep.510240619 · Cited by 99
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes
Korniejewska, A., McKnight, A. J., Johnson, Z., Watson, M. L., & Ward, S. G. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03384.x · Cited by 97
TNF- antagonists beyond approved indications: stories of success and prospects for the future
Karampetsou, M. P., Liossis, S. C., & Sfikakis, P. P. (2010) · QJM · doi:10.1093/qjmed/hcq152 · Cited by 97
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: a single center report of 8 cases
Rodrigues, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i24.7584 · Cited by 97
Jiang, G., Yang, H.-R., Wang, L., Wildey, G. M., Fung, J., Qian, S., & Lu, L. (2008) · Transplantation · doi:10.1097/tp.0b013e31818bfd13 · Cited by 96
Chen, Y., Jeffery, H. C., Hunter, S., Bhogal, R., Birtwistle, J., Braitch, M. K., Roberts, S., Ming, M., Hannah, J., Thomas, C., et al. (2016) · Hepatology · doi:10.1002/hep.28517 · Cited by 86
Rai, R. P., Liu, Y., Iyer, S. S., Liu, S., Gupta, B., Desai, C., Kumar, P., Smith, T., Singhi, A. D., Nusrat, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.047 · Cited by 86
Ferreyra Solari, N. E., Inzaugarat, M. E., Baz, P., De Matteo, E., Lezama, C., Galoppo, M., Galoppo, C., & Cherñavsky, A. C. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9635-2 · Cited by 80
Vonghia, L., Magrone, T., Verrijken, A., Michielsen, P., Van Gaal, L., Jirillo, E., & Francque, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143380 · Cited by 80
Low‐Dose Interleukin‐2 for Refractory Autoimmune Hepatitis
Lim, T. Y., Martínez‐Llordella, M., Kodela, E., Gray, E., Heneghan, M. A., & Fueyo, A. S. (2018) · Hepatology · doi:10.1002/hep.30059 · Cited by 80
Oo, Y. H., Ackrill, S., Cole, R., Jenkins, L., Anderson, P., Jeffery, H. C., Jones, N., Jeffery, L. E., Lutz, P., Wawman, R. E., et al. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.08.001 · Cited by 79
Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
French, J. B., Bonacini, M., Ghabril, M., Foureau, D., & Bonkovsky, H. L. (2016) · Drug Safety · doi:10.1007/s40264-015-0366-9 · Cited by 77
Zhai, M., Liu, Z., Long, J., Zhou, Q., Yang, L., Zhou, Q., Liu, S., & Dai, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-84577-z · Cited by 75
Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis
Derkow, K., Loddenkemper, C., Mintern, J., Kruse, N., Klugewitz, K., Berg, T., Wiedenmann, B., Ploegh, H. L., & Schott, E. (2007) · Hepatology · doi:10.1002/hep.21796 · Cited by 70
Jeffery, H. C., Jeffery, L. E., Lutz, P. L., Corrigan, M., Webb, G. J., Hirschfield, G. M., Adams, D., & Oo, Y. H. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12940 · Cited by 69
STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice†
Sun, R., Park, O., Horiguchi, N., Kulkarni, S., Jeong, W., Sun, H., Radaeva, S., & Gao, B. (2006) · Hepatology · doi:10.1002/hep.21344 · Cited by 68
The induction and function of the anti-inflammatory fate of TH17 cells
Xu, H., Agalioti, T., Zhao, J., Steglich, B., Wahib, R., Vesely, M. C. A., Bielecki, P., Bailis, W., Jackson, R., Perez, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17097-5 · Cited by 66
Self-citationLiu, Y., She, W., Wang, F., Li, J., Wang, J., & Jiang, W. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.09.024 · Cited by 65
Xu, R., Tao, A., Zhang, S., & Zhang, M. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt065 · Cited by 63
Ma, L., Liwen, Z., Yun, Z., Yanbo, D., & Chen, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/3753081 · Cited by 63
Renand, A., Habes, S., Mosnier, J., Aublé, H., Judor, J., Vince, N., Hulin, P., Nedellec, S., Métairie, S., Archambeaud, I., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1202 · Cited by 59
Wiegard, C., Wolint, P., Frenzel, C., Cheruti, U., Schmitt, E., Oxenius, A., Lohse, A. W., & Herkel, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.007 · Cited by 57
Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis
Buitrago‐Molina, L. E., Pietrek, J., Noyan, F., Schlué, J., Manns, M. P., Wedemeyer, H. H., Hardtke‐Wolenski, M., & Jaeckel, E. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102591 · Cited by 57
Roh, Y. S., Kim, J. W., Park, S., Shon, C., Kim, S., Eo, S. K., Kwon, J. K., Lim, C. W., & Kim, B. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.07.011 · Cited by 55
Bovensiepen, C. S., Schakat, M., Sebode, M., Zenouzi, R., Hartl, J., Peiseler, M., Li, J., Henze, L., Woestemeier, A., Schramm, C., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900124 · Cited by 53
Self-citationRegulatory T-cell directed therapies in liver diseases
Oo, Y. H., & Sakaguchi, S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.034 · Cited by 50
Hepatocytes induce Foxp3+ regulatory T cells by Notch signaling
Burghardt, S., Claass, B., Erhardt, A., Karimi, K., & Tiegs, G. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ab0613-342rr · Cited by 48
SCHLAAK, J. F., LÖHR, H., GALLATI, H., MEYER ZUM BÜSCHENFELDE, K.-H., & FLEISCHER, B. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05996.x · Cited by 47
Zheng, C., Yin, S., Yang, Y., Yu, Y., & Xie, X. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.57 · Cited by 46
Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice
Xu, L., Yin, W., Sun, R., Wei, H., & Tian, Z. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306437110 · Cited by 45
Li, M., Zhao, W., Wang, Y., Jin, L., Jin, G., Sun, X., Wang, W., Wang, K., Xu, X., Hao, J., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0246-9 · Cited by 45
Hardtke‐Wolenski, M., Taubert, R., Noyan, F., Sievers, M., Dywicki, J., Schlue, J., Falk, C. S., Ardesjö Lundgren, B., Scott, H. S., Pich, A., et al. (2015) · Hepatology · doi:10.1002/hep.27639 · Cited by 44
A Protective Function of IL-22BP in Ischemia Reperfusion and Acetaminophen-Induced Liver Injury
Kleinschmidt, D., Giannou, A. D., McGee, H. M., Kempski, J., Steglich, B., Huber, F. J., Ernst, T. M., Shiri, A. M., Wegscheid, C., Tasika, E., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700587 · Cited by 44
Self-citationIntrahepatic Activation of Naive CD4+ T Cells by Liver-Resident Phagocytic Cells
Tay, S. S., Wong, Y. C., Roediger, B., Sierro, F., Lu, B., McDonald, D. M., McGuffog, C. M., Meyer, N. J., Alexander, I. E., Parish, I. A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400037 · Cited by 41
Cherñavsky, A. C., Paladino, N., Rubio, A. E., Biasio, M. B. D., Períolo, N., Cuarterolo, M. L., Goñi, J., Galoppo, C., Cañero-Velasco, M. C., Muñoz, A., et al. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.03.004 · Cited by 41
Location, Location, Location: The Impact of Migratory Heterogeneity on T Cell Function
Baaten, B. J. G., Cooper, A. M., Swain, S. L., & Bradley, L. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00311 · Cited by 41
Plaza-Sirvent, C., Schuster, M., Neumann, Y., Heise, U., Pils, M. C., Schulze-Osthoff, K., & Schmitz, I. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.022 · Cited by 38
Manousou, P., Kolios, G., Drygiannakis, I., Koulentaki, M., Pyrovolaki, K., Voumvouraki, A., Notas, G., Bourikas, L., Papadaki, H. A., & Kouroumalis, E. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12032 · Cited by 37
Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan
Takahashi, A., Ohira, H., Abe, K., Zeniya, M., Abe, M., Arinaga‐Hino, T., Torimura, T., Yoshizawa, K., Takaki, A., Kang, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71296-0 · Cited by 36
CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients
Boujedidi, H., Robert, O., Bignon, A., Cassard, A., Renoud, M.-L., Gary‐Gouy, H., Hémon, P., Tharinger, H., Prevot, S., Bachelerie, F., et al. (2014) · Clinical Science · doi:10.1042/cs20130833 · Cited by 35
Direct, Help-Independent Priming of CD81 T Cells by Adeno-Associated Virus-Transduced Hepatocytes†
Wuensch, S. A., Spahn, J., & Crispe, I. N. (2010) · Hepatology · doi:10.1002/hep.23745 · Cited by 33
IL-17 contributes to autoimmune hepatitis
Yu, H., Huang, J., Yang, L., Ai, G., Yan, W., Wang, X., & Ning, Q. (2010) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-010-0446-0 · Cited by 31
Novel therapeutic targets in autoimmune hepatitis
Taubert, R., Hupa-Breier, K. L., Jaeckel, E., & Manns, M. P. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.022 · Cited by 30
Valean, S. D., Acalovschi, M., Dumitrascu, D. L., Ciobanu, L., Nagy, G. A., & Chira, R. I. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1228 · Cited by 28
Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis
John, K., Hardtke‐Wolenski, M., Jaeckel, E., Manns, M. P., Schulze‐Osthoff, K., & Bantel, H. (2017) · Cell Death and Disease · doi:10.1038/s41419-017-0010-y · Cited by 27
Zhao, Y., Zhang, Y., Liu, Y., Liu, Y., Feng, X., Liao, H.-Y., Mieli‐Vergani, G., Ma, Y., & Yan, H. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02487.x · Cited by 25
Shao, X., Qian, Y., Xu, C.-H., Hong, B., Xu, W., Shen, L., Jin, C., Wu, Z., Tong, X., & Yao, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058836 · Cited by 22
Autoimmune hepatitis on the rise
Schramm, C., & Lohse, A. W. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.025 · Cited by 20
Huang, H., & Deng, Z. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.147 · Cited by 18
Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-α or IFN-γ
Zocco, M. A., Carloni, E., Pescatori, M., Saulnier, N., Lupascu, A., Nista, E. C., Novi, M., Candelli, M., Cimica, V., Mihm, S., et al. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.04.015 · Cited by 16
Enhanced Th17 Responses in Patients with Autoimmune Hepatitis
Behfarjam, F., Nasseri‐Moghaddam, S., & Jadali, Z. (2019) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2018.134 · Cited by 16
Lu, J., Iyasu, A., French, B. A., Tillman, B. C., & French, S. W. (2019) · Alcohol · doi:10.1016/j.alcohol.2019.08.008 · Cited by 16
Th1 Cell Induction in Lymph Nodes According to a Red-Blue Chemokine Map
Matloubian, M., & Cyster, J. G. (2012) · Immunity · doi:10.1016/j.immuni.2012.11.007 · Cited by 12
Liberal, R., Grant, C. R., Mieli‐Vergani, G., Vergani, D., & Longhi, M. S. (2012) · Gut · doi:10.1136/gutjnl-2012-302514d.281 · Cited by 6
Cited by
Drug induced liver injury – a 2023 update
Allison, R., Guraka, A., Shawa, I. T., Tripathi, G., Moritz, W., & Kermanizadeh, A. (2023) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2023.2261848 · Cited by 167
“The nature of drug-induced liver injury may further be classified according to the type of hepatic cells affected along with absence or presence of immunogenicity (Muscate, Woestemeier, and Gagliani 2021).”
BackgroundMajor roles of kupffer cells and macrophages in NAFLD development
Park, S., Diaz, J. G., Um, E., & Hahn, Y. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1150118 · Cited by 98
Saggau, C., Bacher, P., Esser, D., Rasa, M., Meise, S., Mohr, N., Kohlstedt, N., Hutloff, A., Schacht, S.-S., Dargvainiene, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.005 · Cited by 79
NLRP3 Inflammasome: A key contributor to the inflammation formation
Zhang, W.-J., Li, K.-Y., Yi, L., Zeng, H.-Y., Chen, S.-Q., & Wang, H. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113683 · Cited by 78
Immunosenescence of T cells: a key player in rheumatoid arthritis
Gao, Y. Q., Cai, W., Zhou, Y., Li, Y., Cheng, J., & Wei, F. (2022) · Inflammation Research · doi:10.1007/s00011-022-01649-0 · Cited by 60
“Self-reactive CD4+ T cell is the most important one in coordinating the inflammatory response [35].”
Background
Metadata
- Authors
- Muscate, F., Woestemeier, A., & Gagliani, N.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Gagliani, Nicola
- Venue
- Seminars in Immunopathology
- Published
- 2021-08
- Volume
- 43
- Issue
- 4
- Pages
- 549-561
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- PMC
- PMC8443520
- OpenAlex
- W3197639828
- Cited by
- 32
- References
- 144
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 10 · 2022: 7 · 2021: 1
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 30 d)
- Locations
- Seminars in Immunopathology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- Funders
- Universitätsklinikum Hamburg-Eppendorf (UKE)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- CD4+ T cells, T cell functional heterogeneity, liver inflammation, T cell polarization, nonalcoholic steatohepatitis, autoimmune hepatitis, immune-mediated liver disease, therapeutic target
- MeSH terms
- Humans, Inflammation, Liver, T-Lymphocytes, CD4-Positive T-Lymphocytes, Hepatitis, Autoimmune, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.